Bank of New York Mellon Corp lowered its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 7.2% during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 13,362,113 shares of the pharmacy operator’s stock after selling 1,042,868 shares during the quarter. Bank of New York Mellon Corp owned 1.25% of Walgreens Boots Alliance worth $1,046,386,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in WBA. Reilly Financial Advisors LLC grew its holdings in Walgreens Boots Alliance by 7.9% in the 2nd quarter. Reilly Financial Advisors LLC now owns 1,367 shares of the pharmacy operator’s stock valued at $107,000 after buying an additional 100 shares during the last quarter. Orrstown Financial Services Inc. grew its holdings in Walgreens Boots Alliance by 14.1% in the 2nd quarter. Orrstown Financial Services Inc. now owns 1,728 shares of the pharmacy operator’s stock valued at $135,000 after buying an additional 213 shares during the last quarter. MCF Advisors LLC grew its holdings in Walgreens Boots Alliance by 68.2% in the 1st quarter. MCF Advisors LLC now owns 1,923 shares of the pharmacy operator’s stock valued at $160,000 after buying an additional 780 shares during the last quarter. Founders Capital Management acquired a new stake in Walgreens Boots Alliance in the 1st quarter valued at approximately $161,000. Finally, Signature Estate & Investment Advisors LLC acquired a new stake in shares of Walgreens Boots Alliance during the 1st quarter worth approximately $197,000. 60.16% of the stock is currently owned by hedge funds and other institutional investors.
Walgreens Boots Alliance, Inc. (WBA) opened at 69.00 on Friday. The company has a market cap of $73.84 billion, a P/E ratio of 17.42 and a beta of 1.25. The firm has a 50-day moving average price of $78.72 and a 200 day moving average price of $80.77. Walgreens Boots Alliance, Inc. has a 12 month low of $68.55 and a 12 month high of $88.00.
Walgreens Boots Alliance announced that its Board of Directors has authorized a share buyback plan on Thursday, June 29th that allows the company to repurchase $5.00 billion in outstanding shares. This repurchase authorization allows the pharmacy operator to buy up to 5.9% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its stock is undervalued.
WARNING: “Walgreens Boots Alliance, Inc. (WBA) Shares Sold by Bank of New York Mellon Corp” was reported by Ticker Report and is the property of of Ticker Report. If you are accessing this piece on another site, it was stolen and republished in violation of United States and international copyright law. The legal version of this piece can be accessed at https://www.tickerreport.com/banking-finance/2956578/walgreens-boots-alliance-inc-wba-shares-sold-by-bank-of-new-york-mellon-corp.html.
Several analysts have recently weighed in on the company. Needham & Company LLC reissued a “buy” rating and set a $94.00 price objective on shares of Walgreens Boots Alliance in a report on Thursday. BidaskClub lowered Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a report on Tuesday, October 3rd. Credit Suisse Group reissued a “buy” rating and set a $97.00 price objective on shares of Walgreens Boots Alliance in a report on Thursday, July 13th. Jefferies Group LLC reissued a “buy” rating and set a $95.00 price objective on shares of Walgreens Boots Alliance in a report on Monday, October 2nd. Finally, Zacks Investment Research raised Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a report on Thursday, October 5th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and fourteen have issued a buy rating to the company. Walgreens Boots Alliance currently has a consensus rating of “Buy” and an average target price of $91.31.
In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the firm’s stock in a transaction on Tuesday, July 25th. The stock was sold at an average price of $79.79, for a total value of $218,305.44. Following the sale, the director now owns 19,151 shares of the company’s stock, valued at approximately $1,528,058.29. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 13.50% of the company’s stock.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related companies with MarketBeat.com's FREE daily email newsletter.